MANSC1: The Ultimate Drug Target and Biomarker (G54682)

Target Name: MANSC1

NCBI ID: G54682

MANSC1: The Ultimate Drug Target and Biomarker

ManScan1 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues. MANSCAN1 has also been shown to play a key role in the development and progression of various diseases, including cancer. As a result, MANSCAN1 has become a promising drug target and biomarker for a variety of diseases.

The discovery and characterization of MANSCAN1 was made by a team of researchers at the University of California, San Diego. The team identified a protein that was highly expressed in brain tissue, and demonstrated that it was involved in the development and maintenance of brain cells. They also showed that the protein was highly expressed in other tissues and that it was involved in the development of various diseases, including cancer.

Since the discovery of MANSCAN1, a number of studies have been conducted to further characterize the protein and its role in disease. These studies have shown that MANSCAN1 is involved in the development and progression of a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the key features of MANSCAN1 is its ability to interact with a variety of different proteins. This makes it an attractive drug target, as it allows for the development of targeted therapies that can specifically target MANSCAN1 and its interacting proteins.

In addition to its potential as a drug target, MANSCAN1 has also been shown to be a valuable biomarker for a variety of diseases. The team that made the original discovery has used MANSCAN1 as a biomarker to diagnose and monitor the progression of various diseases, including cancer. They have shown that the protein is highly expressed in the brains of patients with cancer, and that its levels are correlated with the severity of the disease.

These findings have important implications for the development of cancer therapies. By targeting MANSCAN1 and its interacting proteins, researchers can develop drugs that specifically target these proteins and can be used to treat a wide range of diseases.

In conclusion, MANSCAN1 is a promising drug target and biomarker for a variety of diseases. Its ability to interact with a variety of different proteins makes it an attractive target for targeted therapies, and its role in the development and progression of diseases makes it an important biomarker for diagnostic and prognostic purposes. Further research is needed to fully understand the potential of MANSCAN1 as a drug target and biomarker, and to develop effective therapies that can treat a wide range of diseases.

Protein Name: MANSC Domain Containing 1

More Common Targets